ORL
A Totally Implanted Intra-Arterial Chemotherapy System for Advanced Maxillary Sinus CarcinomaNakatani H.a · Hirose K.a · Matsumoto N.a · Yamakawa K.a, b · Kakigi A.a, c · Takeda T.a · Ito S.d · Yamanishi T.d · Nishioka A.d · Ogawa Y.d · Nakahira M.a, eaDepartment of Otolaryngology, Kochi Medical School, Kochi, bDepartment of Otolaryngology, Ako City Hospital, Hyogo, cDepartment of Otolaryngology, Faculty of Medicine, University of Tokyo, Tokyo, dDepartment of Radiology, Kochi Medical School, Kochi, and eDepartment of Head and Neck Surgery, Saitama Medical University International Medical Center, Comprehensive Cancer Center, Saitama, Japan
|
|
ORL 2009;71(suppl 1):116–122
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
First-Page Preview
Published online: February 24, 2010
Issue release date: February 2010
Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 1
ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)
For additional information: https://www.karger.com/ORL
Abstract
Conclusion: Both reservoir systems for intra-arterial cisplatin and intravenous sodium thiosulfate infusions are low- invasive, safe and effective procedures for treatment of advanced maxillary sinus carcinoma. Objectives: To use our reservoir system for intra-arterial high-dose cisplatin infusion therapy in patients with advanced maxillary sinus carcinoma. Materials and Methods: Eight patients with advanced maxillary sinus carcinomas underwent treatment utilizing intra-arterial cisplatin (CDDP) infusion and radiation therapy followed by planned surgical resection. For intra-arterial infusion of high-dose cisplatin, both intra-arterial and intravenous reservoir systems were used. Results: CDDP was infused 4–6 times (mean 5.1) and the total dose of CDDP was between 690 and 910 mg (mean 771 mg). The response rate was 100 with 50% CR and 50% PR and all patients underwent medial maxillectomy. Only 1 T4 patient had local recurrence and 1 other patient had bilateral neck metastasis.
© 2010 S. Karger AG, Basel
Related Articles:
References
- Isaacs JH Jr, Mooney S, Mendenhall WM, Parsons JT: Cancer of the maxillary sinus treated with surgery and/or radiation therapy. Am Surg 1990;56:327–330.
- Waldron JN, O’Sullivan B, Gullane P, Witterick IJ, Lui FF, Payne D, Warde P, Cummings B: Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 2000;57:167–173.
- Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB: Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364–371.
- Robbins KT, Fontanesi J, Wong FS, Vicario D, Seagren S, Kumar P, Weisman R, Pellitteri P, Thomas JR, Flick P, Palmer R, Weir A 3rd, Kerber C, Murry T, Ferguson R, Los G, Orloff L, Howell SB: A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996;122:853–857.
- Samant S, Kumar P, Wan J, Hanchett C, Vieira F, Murry T, Wong FSH, Ribbins KT: Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 1999;21:595–601.
- Robbins KT, Kumar P, Wong FSH, Hartsell WF, Flick P, Palmer R, Weir AB III, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell S: Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687–693.
- Robbins KT, Kumar P, Harris J, McCulloch T, Cmelak A, Sofferman R, Levine P, Weisman R, Wilson W, Weymuller E, Fu K: Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 2005;23:1447–1454.
- Spring PM, Valentino J, Arnold AM, Sloan D, Kenady D, Kudrimoti M, Haydon RC III, Lee C, Given C, Mohiuddin M, Reqine WF: Long-term results of hyperfractionated radiation and high-dose cisplatin for unresectable oropharyngeal carcinoma. Cancer 2005;104:1765–1771.
- Imai S, Kajihara Y, Munemori O, Kamei T, Mori T, Handa T, Akisada K, Orita Y: Superselective cisplatin (CDDP) – carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol 1995;21:94–99.
- Gemmete JJ: Complications associated with selective high-dose intra-arterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc Interv Radiol 2003;14:743–748.
- Furutani K, Fuwa N, Kodaira A, Matsumoto A, Kamata M, Tachibana H, Sakahara H: Continuous selective intra-arterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol 2002;38:145–152.
- Sessions B, Lehane DE, Smith RJH, Bryan RN, Suen JY: Intra-arterial cisplatin treatment of adenoid cystic carcinoma. Arch Otolaryngol 1982;108:221–224.
- Kovacs AF, Turowski B: Chemoembolization of oral and oropharyngeal cancer using a high-dose cisplatin crystal suspension and degradable starch microspheres. Oral Oncol 2002;38:87–95.
- Rohde S, Kovacs AF, Turowski B, Yan B, Zanella F, Berkefeld J: Intra-arterial high dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer. Am J Neuroradiol 2005;26:1804–1809.
- Wilson WR, Siegel RS, Harisiadis LA, Davis DO, Nquyen HH, Bank WO: High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127:809–812.
- Tohnai I, Fuwa N, Hayashi Y, Kaneko R, Tomaru Y, Hibino Y, Ueda M: New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 1998;34:387–390.
- Fuwa N, Ito Y, Matsumoto A, Kamata M, Kodaira T, Furutani K, Sasaoka M, Kimura Y, Morita K: A combination therapy of continuous superselective intra-arterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Cancer 2000;89:2099–2105.
- Lee YY, Dimery IW, Tassel PV, Pena CD, Blacklock JB, Goepfert H: Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otolaryngol Head Neck Surg 1989;115:503–511.
- Samant S, Robbins KT, Vang M, Wan J, Robertson J: Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg 2004;130:948–955.
- Shiga K, Yokoyama J, Hashimoto S, Saijo S, Tateda M, Ogawa T, Watanabe M, Kobayashi T: Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg 2007;136:1003–1009.
- Shimizu T, Sakakura Y, Hattori T, Yamaguchi N, Kubo M, Sakakura K: Superselective intra-arterial chemotherapy in combination with irradiation: preliminary report. Am J Otolaryngol 1990;11:131–136.
Article / Publication Details
First-Page Preview
Published online: February 24, 2010
Issue release date: February 2010
Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 1
ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)
For additional information: https://www.karger.com/ORL
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
